Skip to main navigation Skip to search Skip to main content

100 A 16-Year Multi-Institutional Study of the Role of Age and EBV Status on PTLD Incidence among Pediatric Heart Transplant Recipients

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Purpose: We determined the incidence and risk for PTLD among children as a function of age at time of transplant and EBV serology status. Methods and Materials: Malignancy data were obtained from 3,170 pediatric patients (birth-18yrs) with a median follow-up of 3.85 years at 35 institutions in the Pediatric Heart Transplant Study between 1993 and 2009. PTLD and EBV status were analyzed as a function of transplant year, transplant age, and demographic variables. (Figure Presented) Results: Of 151 malignancy events, 147 (97%) were PTLD. Actuarial freedom from PTLD was lowest among patients From birth to 10 years of age, with the peak hazard for PTLD at one year post-transplantation occurring in patients 5.45 years old at transplant, (left panel). Among recipients of EBV+ donor hearts, EBV-recipients exhibited an increased risk of PTLD (p
Original languageAmerican English
Pages (from-to)S41
JournalJournal of Heart and Lung Transplantation
Volume30
Issue number4
DOIs
StatePublished - Apr 1 2011

Disciplines

  • Pediatrics
  • Medicine and Health Sciences

Cite this